Biologics

Top Story

More than half of patients in AS remission relapse after ceasing infliximab

April 26, 2019
Meeting News

Surgeon’s job with new surface technologies: Provide contact bone, achieve stable motion segments

September 27, 2018
LOS ANGELES — From the surgeon’s perspective, host bone, biologic factors and implants are key considerations when it comes to new surface materials used in…

FDA approves trial of peptide-enhanced bone graft vs autograft for TLIF

March 29, 2018
Cerapedics announced the company received FDA approval to initiate an investigational device exemption clinical trial evaluating the safety and efficacy of P-15L Peptide…

Bioventus, LifeLink to co-develop next generation bone allograft for spine, trauma surgery

March 4, 2018
Bioventus announced it has entered into an agreement with LifeLink Tissue Bank to co-develop a next generation bone allograft for spine and trauma surgery, according to…
More Headlines »